RANBP2 and metabolic dysfunction-associated steatohepatitis: Our study revealed significant nuclear/perinuclear co-localization of RanBP2 with SHP, which was strongly associated with serum hepatitis markers and the degree of hepatic steatosis in patients with MASH.